Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-10-26 Purchase |
2022-10-28 2:57 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
2,000,000 | $4.1098 | $8,219,600 | 7,879,583 (Direct) |
View |
2022-07-18 Purchase |
2022-07-20 3:21 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
300,000 | $3.1558 | $946,740 | 5,879,583 (Direct) |
View |
2022-07-14 Purchase |
2022-07-18 12:48 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
588,869 | $2.9314 | $1,726,226 | 5,579,583 (Direct) |
View |
2022-06-30 Purchase |
2022-07-05 1:39 pm |
ESSA Pharma Inc. | EPIX | Parkinson David Ross Chief Executive Officer |
4,887 | $2.958 | $14,456 | 32,108 (Direct) |
View |
2022-04-27 Sale |
2022-04-28 12:28 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
25,100 | $5.8536 | $146,925 | 4,990,714 (Direct) |
View |
2021-08-18 Purchase |
2021-08-20 12:43 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
250,000 | $8.8752 | $2,218,800 | 5,015,814 (Direct) |
View |
2021-02-22 Purchase |
2021-03-04 6:47 pm |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
57,000 | $27 | $1,539,000 | 957,244 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-29 Option Award |
2022-11-01 11:06 am |
N/A 2032-06-29 |
ESSA Pharma Inc. | EPIX | Parkinson David Ross Chief Executive Officer |
222,500 | $0 | 222,500 (Direct) |
View |
2022-06-29 Option Award |
2022-11-01 11:06 am |
N/A 2032-06-29 |
ESSA Pharma Inc. | EPIX | Martin John Alexander Director |
22,500 | $0 | 22,500 (Direct) |
View |
2022-06-29 Option Award |
2022-11-01 11:05 am |
N/A 2032-06-29 |
ESSA Pharma Inc. | EPIX | Glickman Richard M Director |
35,000 | $0 | 35,000 (Direct) |
View |
2022-06-29 Option Award |
2022-11-01 11:05 am |
N/A 2032-06-29 |
ESSA Pharma Inc. | EPIX | Cesano Alessandra Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2022-06-29 Option Award |
2022-11-01 11:04 am |
N/A 2032-06-29 |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
22,500 | $0 | 22,500 (Direct) |
View |
Ownership |
2022-09-21 7:39 pm |
N/A 2032-09-13 |
ESSA Pharma Inc. | EPIX | Kantoff Philip W. Director |
0 | $0 | 50,000 (Direct) |
View |
Ownership |
2022-07-21 7:26 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 11,481,841 (Direct) |
View |
Ownership |
2021-08-17 2:07 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
0 | $0 | 4,765,814 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:03 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | ZWEIFACH SANFORD S Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:03 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Thorell Marella Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:03 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Sollis Gary Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:02 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:02 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Martin John Alexander Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:02 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Glickman Richard M Director |
25,000 | $0 | 25,000 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:01 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Brettman Ari David Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award(A) |
2021-01-26 7:01 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:47 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | ZWEIFACH SANFORD S Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:47 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Wood David S. Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:46 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Virsik Peter Chief Operating Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:46 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Thorell Marella Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:46 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Sollis Gary Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:45 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:45 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Parkinson David Ross Chief Executive Officer |
266,948 | $0 | 266,948 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:44 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Martin John Alexander Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:44 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Glickman Richard M Director |
25,000 | $0 | 25,000 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:43 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Cesano Alessandra Chief Medical Officer |
57,500 | $0 | 57,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:43 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Brettman Ari David Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-11 Option Award |
2021-01-11 4:42 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
16,500 | $0 | 941,537 (Direct) |
View |
2020-12-03 Exercise |
2021-01-11 4:42 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
6,773 | $4.67 | 941,537 (Direct) |
View |
2020-12-03 Exercise |
2021-01-11 4:42 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
8,250 | $4 | 941,537 (Direct) |
View |
2020-12-03 Exercise |
2021-01-11 4:42 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
2,184 | $3.81 | 941,537 (Direct) |
View |
2020-12-03 Exercise |
2021-01-11 4:42 pm |
2022-03-21 2025-03-05 |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
42,207 | $0 | 941,537 (Direct) |
View |
2020-12-03 Exercise |
2021-01-11 4:42 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director |
25,000 | $3.23 | 941,537 (Direct) |
View |
Ownership |
2020-10-02 7:17 pm |
2023-11-04 2029-10-04 |
ESSA Pharma Inc. | EPIX | ZWEIFACH SANFORD S Director |
0 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-10-02 7:16 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | Martin John Alexander Director |
0 | $0 | 64,299 (Direct) |
View |
Ownership |
2020-10-01 7:04 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | Thorell Marella Director |
0 | $0 | 52,881 (Direct) |
View |
Ownership |
2020-10-01 7:03 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | Clarus Lifesciences III L.P. Clarus Ventures III GP L.P. Blackstone Clarus III L.L.C. Blackstone Holdings II L.P. Blackstone Holdings I/II GP L.L.C. Blackstone Group Inc Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner |
0 | $0 | 3,729,114 (Indirect) |
View |
Ownership |
2020-10-01 7:03 pm |
2022-03-21 2024-05-21 |
ESSA Pharma Inc. | EPIX | Sollis Gary Director |
0 | $0 | 67,000 (Direct) |
View |